Sustained virological response prevents the development of insulin resistance in patients with chronic hepatitis C

Impact of Insulin Resistance on HCV Treatment Response and Impact of HCV Treatment on Insulin Sensitivity Using Direct Measurements of Insulin Action

(2012) D. Brandman et al.   DIABETES CARE

HCV Infection and Metabolic Syndrome: Which Is the Chicken and Which Is the Egg?

(2012) Francesco Negro   GASTROENTEROLOGY

The interaction of metabolic factors with HCV infection: Does it matter?

(2012) Elisabetta Bugianesi et al.   JOURNAL OF HEPATOLOGY

Clinical drivers in naïve patient eligibility for treatment of chronic hepatitis C

(2012) E. Degasperi et al.   JOURNAL OF VIRAL HEPATITIS

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response

(2012) P. J. Clark et al.   JOURNAL OF VIRAL HEPATITIS

Meta-analysis: insulin resistance and sustained virological response in hepatitis C

(2011) M. Eslam et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Viral clearance is associated with improved insulin resistance in genotype 1 chronic hepatitis C but not genotype 2/3

(2011) Alexander J Thompson et al.   GUT

Impact of insulin resistance on sustained response in HCV patients treated with pegylated interferon and ribavirin: A meta-analysis

(2011) Pierre Deltenre et al.   JOURNAL OF HEPATOLOGY

EASL Clinical Practice Guidelines: Management of hepatitis C virus infection

(2011)   JOURNAL OF HEPATOLOGY

Use of HOMA-IR in hepatitis C

(2011) M. Eslam et al.   JOURNAL OF VIRAL HEPATITIS

Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection

(2011) Bruce R. Bacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Telaprevir for Retreatment of HCV Infection

(2011) Stefan Zeuzem et al.   NEW ENGLAND JOURNAL OF MEDICINE

The homeostasis model assessment of the insulin resistance score is not predictive of a sustained virological response in chronic hepatitis C patients

(2010) Giovanna Fattovich et al.   LIVER INTERNATIONAL

Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C

(2009) Maria Grazia Rumi et al.   GASTROENTEROLOGY

Treatment of insulin resistance with metformin in naïve genotype 1 chronic hepatitis C patients receiving peginterferon alfa-2a plus ribavirin

(2009) Manuel Romero-Gómez et al.   HEPATOLOGY

Steatosis and insulin resistance in hepatitis C: A way out for the virus?

(2009) José A Del Campo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Insulin Resistance Among Patients With Chronic Hepatitis C: Etiology and Impact on Treatment

(2008) S HARRISON   Clinical Gastroenterology and Hepatology

Hepatitis C virus infection: Molecular pathways to metabolic syndrome

(2008) Muhammad Y. Sheikh et al.   HEPATOLOGY

Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C

(2008) Yasuji Arase et al.   HEPATOLOGY

Effect of sustained virological response to treatment on the incidence of abnormal glucose values in chronic hepatitis C

(2008) Manuel Romero-Gómez et al.   JOURNAL OF HEPATOLOGY

Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis

(2008) Donna L. White et al.   JOURNAL OF HEPATOLOGY

Insulin Resistance in Chronic Hepatitis C: Association With Genotypes 1 and 4, Serum HCV RNA Level, and Liver Fibrosis

(2007) Rami Moucari et al.   GASTROENTEROLOGY

Insulin resistance and response to therapy in patients infected with chronic hepatitis C virus genotypes 2 and 3

(2007) Hossein Poustchi et al.   JOURNAL OF HEPATOLOGY